Evidence map›Paper›PMID 42179784›Full record

ArticleJournal of Cancer2026

Wuhou Dai, Dong Xu, Yubin Lei, Shujing Zhang, Tonglu Yu, Wufan Tao, Xiaofeng Chen, Xingrong Du

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wuhou DaiHuashan Hospital and School of Life Sciences, Fudan University, Shanghai, P.R. China.
Dong XuHuashan Hospital, Fudan University, Shanghai, P.R. China.
Yubin LeiHuashan Hospital and School of Life Sciences, Fudan University, Shanghai, P.R. China.
Shujing ZhangHuashan Hospital and School of Life Sciences, Fudan University, Shanghai, P.R. China.
Tonglu YuHuashan Hospital and School of Life Sciences, Fudan University, Shanghai, P.R. China.
Wufan TaoHuashan Hospital and School of Life Sciences, Fudan University, Shanghai, P.R. China.
Xiaofeng ChenHuashan Hospital, Fudan University, Shanghai, P.R. China.
Xingrong DuShanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Drug Clinical Trial Center, Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University; Institute of Clinical Mass Spectrometry, Shanghai Academy of Experimental Medicine, Shanghai, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains the leading cause of cancer-related mortality worldwide, yet its molecular pathogenesis is not fully understood. Here, we identify

Indexed as

ChopER stressHadhblung cancer

Identifiers

PMID42179784
PMCPMC13189847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.